Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

E Rubio-Beltran, A Labastida-Ramirez, CM Villalon, Antoinette Maassen van den Brink

Research output: Contribution to journalArticleAcademicpeer-review

61 Citations (Scopus)
2 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)88-97
Number of pages10
JournalPharmacology & Therapeutics
Volume186
DOIs
Publication statusPublished - 2018

Cite this